| Compound loss of muscleblind‐like function in myotonic dystrophy KY Lee, M Li, M Manchanda, R Batra, K Charizanis, A Mohan, SA Warren, ... EMBO molecular medicine 5 (12), 1887-1900, 2013 | 182 | 2013 |
| Results of the ICTuS 2 trial (intravascular cooling in the treatment of stroke 2) P Lyden, T Hemmen, J Grotta, K Rapp, K Ernstrom, T Rzesiewicz, ... Stroke 47 (12), 2888-2895, 2016 | 159 | 2016 |
| Myosin light chain phosphorylation is critical for adaptation to cardiac stress SA Warren, LE Briggs, H Zeng, J Chuang, EI Chang, R Terada, M Li, ... Circulation 126 (22), 2575-2588, 2012 | 114 | 2012 |
| Ablation of Nkx2-5 at mid-embryonic stage results in premature lethality and cardiac malformation R Terada, S Warren, JT Lu, KR Chien, A Wessels, H Kasahara Cardiovascular research 91 (2), 289-299, 2011 | 97 | 2011 |
| Slow progressive conduction and contraction defects in loss of Nkx2-5 mice after cardiomyocyte terminal differentiation M Takeda, LE Briggs, H Wakimoto, MH Marks, SA Warren, JT Lu, ... Laboratory investigation 89 (9), 983-993, 2009 | 56 | 2009 |
| Differential role of Nkx2-5 in activation of the atrial natriuretic factor gene in the developing versus failing heart SA Warren, R Terada, LE Briggs, CT Cole-Jeffrey, WM Chien, T Seki, ... Molecular and cellular biology 31 (22), 4633-4645, 2011 | 46 | 2011 |
| Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase MT Massengill, HM Ashraf, RR Chowdhury, SM Chrzanowski, J Kar, ... Cardiovascular Research 111 (1), 34-43, 2016 | 32 | 2016 |
| Ctim-04. Updates for a Phase 2 Open-Labeled Study of Pembrolizumab Plus Ttfields Plus Maintenance Temozolomide in Patients with Newly Diagnosed Glioblastoma (2-the-Top) A Ghiaseddin, S Warren, A Allen, D Sampson, D Chen, A Sherman, ... Neuro-Oncology 22 (Suppl 2), ii33, 2020 | 5 | 2020 |
| ATIM-39. Phase 2 open-labeled study of adjuvant temozolomide plus tumor treating fields plus pembrolizumab in patients with newly diagnosed glioblastoma (2-THE-TOP) D Tran, S Warren, A Allen, D Sampson, D Chen, N Thomas, V Greene, ... Neuro-Oncology 21 (Suppl 6), vi10, 2019 | 3 | 2019 |
| Compound loss of muscleblind-like function in myotonic dystrophy. EMBO Mol Med. 2013; 5 (12): 1887–900 KY Lee, M Li, M Manchanda, R Batra, K Charizanis, A Mohan | 3 | |
| PATH-27. Identifying the genetic signature of response in a phase II study of tumor treating fields in recurrent glioblastoma D Tran, S Warren, W Friedman, A Ghiaseddin, G Murad, M Rahman, ... Neuro-oncology 20 (Suppl 6), vi164, 2018 | 1 | 2018 |
| Predictors of atrial fibrillation in patients with cryptogenic stroke (P6. 294) S Renati, L Almeida, S Warren, C Wilson Neurology 88 (16 Supplement), 2017 | 1 | 2017 |
| IMMU-42. DUAL ACTIVATION OF THE cGAS-STING PATHWAY AND AIM2-INDUCED PYROPTOSIS BY TUMOR-TREATING FIELDS PRODUCES ANTI-TUMOR IMMUNITY IN GLIOBLASTOMA D Chen, M Sebastian, T Hutchinson, A Ghiaseddin, S Warren, A Allen, ... Neuro-Oncology 22 (Suppl 2), ii113, 2020 | | 2020 |
| ATIM-03. TTFIELDS AND PULSED BEVACIZUMAB IN PATIENTS WITH BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA: A PHASE 2 STUDY D Tran, A Ghiaseddin, J Campian, S Staal, S Warren, A Allen, D Sampson, ... Neuro-Oncology 20 (Suppl 6), vi1, 2018 | | 2018 |
| ACTR-29. A PHASE 2 STUDY OF TTFIELDS AND PULSED BEVACIZUMAB IN PATIENTS WITH BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA D Tran, A Ghiaseddin, J Campian, S Staal, S Andrews, S Warren, ... Neuro-Oncology 19 (Suppl 6), vi7, 2017 | | 2017 |
| Journal of the European Society of Cardiology KR Sipido, P Holvoet, S Janssens, A Luttun, M Sampaolesi | | 2017 |
| Long-term Outcome Analysis in Patients With Malignant Middle Cerebral Artery Stroke Who Underwent Decompressive Hemicraniectomy J Xu, SA Warren, AY Khanna STROKE 46, 2015 | | 2015 |
| Abstract T P289: Long-term Outcome Analysis in Patients With Malignant Middle Cerebral Artery Stroke Who Underwent Decompressive Hemicraniectomy J Xu, SA Warren, AY Khanna Stroke 46 (suppl_1), ATP289-ATP289, 2015 | | 2015 |
| Acute Cardiac Dysfunction by Adult-onset Cardiac Myosin Light Chain Kinase Ablation M Massengill, E Chang, H Ashraf, S Chrzanowski, R Chowdhury, J Kar, ... Circulation 130 (suppl_2), A17911-A17911, 2014 | | 2014 |
| Myosin Light Chain Phosphorylation is Critical for Adaptation to Cardiac Stress H Kasahara, S Warren, L Briggs, H Zeng, J Chuang, E Chang, R Terada, ... Circulation 126 (suppl_21), A16614-A16614, 2012 | | 2012 |
